Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Long-acting beta-agonist

Long-acting beta-agonist

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FF/UMEC/VI Triples Odds of Asthma Clinical Remission at 52 Weeks
Allergy & Immunology RCT
FF/UMEC/VI Triples Odds of Asthma Clinical Remission at 52 Weeks Trial shows triple therapy improves outcomes for uncontrolled asthma patients
In this 52-week, open-label randomized trial of 1236 adults with uncontrolled, infrequently exacerbating asthma, fluticasone furoate/umeclid…
A new triple-medication inhaler significantly increases the odds of achieving clinical remission for adults with uncontrolled, stable asthma…
Oct 1, 2026
Meta-analysis finds inhaled corticosteroids associated with reduced cardiovascular mortality in COPD patients
Pulmonology & Critical Care Meta-analysis
Meta-analysis finds inhaled corticosteroids associated with reduced cardiovascular mortality in COPD patients A Common COPD Medicine May Also Protect Your Heart
A systematic review and meta-analysis of 74,004 COPD patients found inhaled corticosteroid-containing formulations were associated with redu…
For people with COPD, a medication they already use to breathe easier might also offer a hidden layer of protection for their heart.
Apr 9, 2026